Mutation JAK2 V617F in patients with myeloproliferative disorders and technical aspects of its detection.

被引：0
|
作者：
Pekova, Sona
Hoffmann, Rudolf
Jindra, Pavel
Novakova, Ludmila
Kozak, Tomas
Vozobulova, Vera
Schutzova, Miroslava
Balasz, Jozef
Tomsikova, Lucie
Prucha, Miroslav
机构：
[1] Hosp Na Homolce, Dept Clin Biochem Hematol & Oncol, Prague, Czech Republic
[2] Fac Hosp, Dept Hematol Oncol, Plzen, Czech Republic
[3] Fac Hosp Kralovske Vinohrady, Dept Clin Hematol, Prague, Czech Republic
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.4906.4906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4906
引用
收藏
页码：313B / 313B
页数：1
相关论文
共 50 条
  • [21] No evidence for amplification of V617F JAK2 in myeloproliferative disorders
    A V Jones
    D J Bunyan
    N C P Cross
    Leukemia, 2007, 21 : 2561 - 2563
  • [22] Presence of JAK2 V617F mutation in myeloproliferative and myelodysplastic syndrome patients
    Duarte, F.
    Santos, T.
    Barbosa, M.
    Santos, T.
    Goncalves, R.
    LEUKEMIA RESEARCH, 2013, 37 : S99 - S100
  • [23] Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms
    Chadi, Soumaya
    Dhaouadi, Tarak
    Sfar, Imen
    Baccouche, Hela
    Nabli, Rym
    Ben Romdhane, Neila
    Ben Abdallah, Taieb
    Gorgi, Yousr
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [24] The Janus kinase 2 (JAK2) V617F mutation in Chinese patients with chronic myeloproliferative disorders
    Xiao, Zhijian
    Zhang, Yue
    Li, Lin
    Nie, Ling
    Yang, Lin
    Xu, Shicai
    HAEMATOLOGICA, 2008, 93 (05) : 787 - 788
  • [25] Concomitant BCR ABL Translocation and JAK2 V617F Mutation in Myeloproliferative Disorders
    Hummel, J. M.
    Sanks, J.
    Chiselite, M.
    Smith, L. B.
    Johnson, K. Elenitoba
    Lim, M. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [26] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
  • [27] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [28] Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
    Kralovics, Robert
    Teo, Soon-Siong
    Li, Sai
    Theocharides, Alexandre
    Buser, Andreas S.
    Tichelli, Andre
    Skoda, Radek G.
    BLOOD, 2006, 108 (04) : 1377 - 1380
  • [29] The JAK2 V617F mutation in patients with anaemia
    S. E. Langabeer
    Irish Journal of Medical Science (1971 -), 2017, 186 : 349 - 350
  • [30] The JAK2 V617F mutation in patients with anaemia
    Langabeer, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
12345